Interaction of morphine-epoxide with multiple opiate receptors

Area of Science:

• Pharmacology
• Neuroscience
• Biochemistry

Background:

• Morphine is a widely used opioid analgesic.
• The identification and characterization of morphine metabolites are crucial for understanding its pharmacological effects and metabolism.
• Morphine-epoxide was hypothesized as a novel metabolite of morphine.

Purpose of the Study:

• To investigate the interaction of morphine-epoxide with opiate receptor subtypes.
• To compare the pharmacological and biochemical properties of morphine-epoxide with morphine and naloxone.

Main Methods:

• Pharmacological assays using guinea pig ileum and mouse vas deferens.
• Biochemical binding assays with radiolabeled ligands ([3H]-dihydromorphine and [3H]-D-ala2-D-leu5 enkephalin) on rat brain membrane preparations.
• Analysis of "sodium ratio" and "GTP ratio" to determine receptor activation mechanisms.

Main Results:

• Morphine-epoxide demonstrated 3-4 times less potency than morphine in opiate receptor interactions.
• The binding and functional profiles of morphine-epoxide were similar to morphine, indicating mu-type opiate receptor agonism.
• Morphine-epoxide showed minimal effect on rabbit and rat vas deferens twitch responses.
• "Sodium ratio" and "GTP ratio" for morphine-epoxide resembled morphine, differentiating it from naloxone.

Conclusions:

• Morphine-epoxide acts as an agonist at the mu-type opiate receptor.
• Despite slightly lower affinity, morphine-epoxide shares functional characteristics with morphine.
• These findings support morphine-epoxide as a biologically active metabolite of morphine.